In partnership with
AIHealthTech Insider: Issue #121
October 5, 2026
Could a 20-second voice recording reveal a health clue?
Researchers tested AI for signs of diabetes in people’s voices. It identified many people with diabetes—but also flagged nearly half of those without it.
Here’s what the findings mean. Also inside: AI heart and skin checks, a rare genetic diagnosis, and a closer look at GLP-1 drugs and cancer risk.
Summaries are for education, not medical advice. Always verify locally before clinical use.
☕ Quick question before we dive in 👇
Image: AI-generated, AIHealthTech Insider
If your smartwatch could talk, what would it say most often?
👇 Later in this issue: GLP-1 drugs were linked to lower cancer risk—but the study cannot prove they prevent cancer.
🔬 The Big Story
Could AI hear diabetes clues in your voice?
Researchers tested an AI model that analyzes 20-second voice recordings for signs of type 2 diabetes.
Image: AI-generated, AIHealthTech Insider
In an 801-person subgroup checked against blood tests, it identified 82% of people with diabetes but falsely flagged 47% without it.
Why it matters: With further testing, a short recording could help identify who needs a diabetes blood test.
The honest part: These EASD 2026 findings need clinical validation. Performance varied across groups, and the tool cannot replace blood testing.
New here? Join 1,500+ readers getting one carefully sourced AI-healthcare briefing every Monday—written in plain English, without the hype.
🤎 Sponsored
The CBD Brand that Actually Does What It Says
CBD is having a moment and CBD brands are everywhere right now. But with so many options, it can be tough to know what to look for – and which brands actually follow through on their claims.
That’s where CBDistillery sets itself apart. For the past decade, all of CBDistillery's products have been made with non-GMO, US-grown industrial hemp and with 100% clean ingredients – no corn syrup or artificial colors, flavors, preservatives or sweeteners.
They frequently introduce new and innovative products formulated to meet a variety of wellness needs and customer preferences. And every single batch of CBDistillery’s gummies, oil tinctures, topicals and softgels are tested by an independent, accredited lab to make sure what’s in the package matches what’s on the label.
Right now, CBDistillery is offering our readers a special deal: save 50% on orders of $75 or more with code NEWS50!
⚡ Quick Hits
🔸A Routine Heart Test May Hold a Hidden Clue
Yale’s AI analyzes images from a routine ECG, a test that records the heart’s electrical activity. It looks for signs of a condition involving protein buildup in the heart.
Image: AI-generated, AIHealthTech Insider
Across eight external patient groups, its ability to distinguish people with the condition from those without it varied, with AUC scores of 0.76 to 0.91.
The honest part: It could help identify who needs further testing. Researchers still need to show that using it improves patient care.
🔸AI Skin Checks Saved Time—but Missed Six Cancers
Researchers studied AI-assisted skin checks in 8,391 patients at two UK hospitals. They estimated the time saved could equal 8,500 additional appointments over 16 months.
Image: AI-generated, AIHealthTech Insider
The honest part: Those are estimated time savings, not appointments already delivered. Follow-up monitoring identified six missed cancers, showing why continued checks matter.
Know someone in healthcare, medicine, or AI? Forward this to them. They can subscribe free here →
🧬 Clinical Research
Could GLP-1 drugs affect cancer risk, too?
Research revisit — June 2026.
Researchers compared 161,798 matched adults with obesity who did not have diabetes. GLP-1 use was associated with a 41% lower relative cancer hazard, meaning a lower rate of obesity-associated cancers occurring during follow-up. The men’s subgroup showed a 68% lower hazard.
Image: AI-generated, AIHealthTech Insider
The honest part: This observational study cannot prove the drugs prevent cancer. These are relative reductions—not a 41- or 68-percentage-point drop in someone’s cancer risk.
🤎 Sponsored
Experts say to ditch your old cutting boards, here’s why
Your old plastic and wood cutting boards could be making you sick from microplastics, toxic mold, and hidden bacteria. Here’s the hottest-selling upgrade.
🧠 Brain in Brief
AI helped researchers investigate a child’s unexplained condition
Baylor’s AI-MARRVEL flagged a change in a gene called BRSK1 after standard analysis had not explained a child’s condition.
Image: AI-generated, AIHealthTech Insider
Researchers studied 10 affected people from seven families, with additional evidence from fruit-fly experiments.
The honest part: This small study supports a rare genetic diagnosis. It did not establish a treatment.
What’s still sitting on your to-do list?
You don’t need an AI team to build an AI agent. With Skydive, the person who knows the work can create the agent to do it.
Start an agent off with a role, teach them how your team operates, connect your tools, and put them to work.
🌿 Worth Knowing
Could your watch choose a better time for a movement reminder?
Mount Sinai researchers used Fitbit data from 134 women with chronic pelvic pain and 61 comparison participants to predict long periods of sitting.
Image: AI-generated, AIHealthTech Insider
The research could help design reminders that arrive when someone is likely to stay seated.
The honest part: The models predicted behavior. Whether those reminders reduce sitting or improve symptoms still needs clinical testing.
Stay ahead of AI Healthcare
An earlier warning is useful only if it leads to better care.
This week’s research offers promising clues. The next step is to test whether using them makes a difference for patients.
We’ll keep following the evidence—and explaining what it means in plain English.
